UFC bantamweight Miles Johns has been given a public warning by USADA for failing to obtain a Therapeutic Use Exemption (TUE) for prescribed medication.
Johns, who tested positive for Adderall following his most recent fight, a loss to John Castenada at UFC Vegas 47 in February, will not receive further punishment for the infraction. The 28-year old was prescribed the substance by a physician to treat a diagnosed medical condition; he did not, however, notify USADA and follow the proper procedure to obtain a TUE.
USADA (U.S. Anti-Doping Agency) oversees the UFC’s Anti-Doping program, as they have since 2015.
As noted in a press release announcing the warning on Thursday, Johns subsequently submitted the required paperwork to obtain a TUE for the medication.
Johns’ case also fell under the jurisdiction of the Nevada State Athletic Commission, which previously handed down a six-month suspension for the fighter. He’ll be eligible to return to competition on August 5, 2022. A fine also applied.
A former LFA bantamweight champion, Miles Johns (12-2) won his way into the UFC by way of Dana White’s Contender Series in 2019. He’s posted a 3-2 record to date, with wins over Cole Smith, Kevin Natividad, and Anderson dos Santos. Two of those wins, coming back-to-back against Natividad and dos Santos, earned Johns Performance of the Night bonuses.
Johns does not currently have a fight scheduled.
